Virtual screening of the active ingredients of Shufeng Jiedu capsule for COVID-19 based on molecular docking and network pharmacology
Journal of Pharmaceutical Research
; 40(9):590-597, 2021.
Article
in Chinese
| CAB Abstracts | ID: covidwho-1726936
ABSTRACT
Objective:
To screen potential active ingredients of Shufeng Jiedu Capsule(SJC)for novel coronavirus pneumonia(COVID-19).
Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Pesticides and Drugs; Control [HH405]; Non-food/Non-feed Plant Products [SS200]; Animal and in vitro Models for Pharmaceuticals [VV450]; Information and Documentation [CC300]; human diseases; viral diseases; bioinformatics; interleukin 6; gene expression; genes; glycoproteins; hydrolases; ligands; pharmacology; screening; synergism; tumour necrosis factor; traditional Chinese medicines; herbal drugs; antiviral properties; coronavirus disease 2019; databases; interleukin 17; man; Severe acute respiratory syndrome coronavirus 2; Human herpesvirus 5; Human herpesvirus 8; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Cytomegalovirus; Betaherpesvirinae; Herpesviridae; Herpesvirales; dsDNA Viruses; DNA Viruses; Rhadinovirus; Gammaherpesvirinae; Shufeng Jiedu; SARS-CoV-2; viral infections; screening tests; synergy; cachectin; cachexin; tumor necrosis factor; herbal medicines; anti-viral properties; data banks; Human cytomegalovirus
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
Chinese
Journal:
Journal of Pharmaceutical Research
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS